Cases & Deals

Idenix asserts patent infringement against Gilead in UK related to Sovaldi® and Harvoni®

Client(s) Idenix Pharmaceuticals LLC

Jones Day represented Idenix Pharmaceuticals LLC (a subsidiary of Merck & Co., Inc.) in patent litigation against Gilead in the Patents Court and Court of Appeal in the UK over sofosbuvir, the active ingredient in Sovaldi® and Harvoni®, Gilead's blockbuster drugs for treating Hepatitis C. Subject matter is nucleoside analogs and prodrugs for treating Flaviviridae infections, including HCV.

Idenix Pharmaceuticals v. Gilead Sciences Inc and others; HP14D01069 (Patents Court) and A3/2015/0450 (Court of Appeal)